James Basta Sells $16.7K of Intellia Therapeutics Inc (NTLA) — SEC Form 4, Mar 03, 2026

Open-Market Net Sale · SEC Form 4
−$16,688

Equity position changed by +39.7%

Reporting Owner
TXN 2026-03-02 · FILED 2026-03-03
Equity Position 158K sh 113,136 → 158,005
Equity Change +39.7% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-03-03
Report Date
2026-03-03
Accession No.
0001193125-26-088260
Accepted At
2026-03-03 21:18 UTC
Reporting Owner
Name Relationship
James Basta CIK 0001792726
GC
James Basta at Intellia Therapeutics Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $112,444
More from this insider at Intellia Therapeutics Inc
2026-01-07 Sell -$95,756 View
2025-03-04 Sell -$23,122 View
2025-01-07 Sell -$86,161 View
2024-03-05 Sell -$75,778 View
2024-01-05 Sell -$112,095 View
All filings by this insider at Intellia Therapeutics Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-03-01 A - Award/Grant 46,080 A $0.00 — 158,005 Direct
Common StockF2 2026-03-02 S - Sale 1,211 D $13.78 -$16,688 156,794 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Stock Option (right to buy)F3 $13.78 2026-03-01 A - Award/Grant 65,829 A $0.00 2036-02-29 65,829 Common Stock Direct
Footnotes (3)
F1
Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit Show more
F2
Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2026, and does not represent a volitional trade by the Reporting Person. Show more
F3
This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. Show more
5%+ Holders · 13D/G 5 filers
Other insiders at Intellia Therapeutics Inc
All Intellia Therapeutics Inc insider activity
GET /v1/forms/4/0001193125-26-088260 API docs
View Original SEC Filing